Racial Differences in Anti-VEGF Intravitreal Injections Among Commercially Insured Beneficiaries
BACKGROUND AND OBJECTIVE: This study assessed racial and ethnic differences in receiving anti-vascular endothelial growth factor (VEGF) intravitreal injections among commercially insured patients
Publié dans: | Ophthalmic surgery, lasers & imaging retina. - 2013. - 52(2021), 4 vom: 10. Apr., Seite 208-217 |
---|---|
Auteur principal: | |
Autres auteurs: | , |
Format: | Article en ligne |
Langue: | English |
Publié: |
2021
|
Accès à la collection: | Ophthalmic surgery, lasers & imaging retina |
Sujets: | Journal Article Angiogenesis Inhibitors Recombinant Fusion Proteins Vascular Endothelial Growth Factor A Bevacizumab 2S9ZZM9Q9V Receptors, Vascular Endothelial Growth Factor EC 2.7.10.1 Ranibizumab ZL1R02VT79 |
Accès en ligne |
Volltext |